Remifentanil Negatively Regulates RANKL-Induced Osteoclast Differentiation and Bone Resorption by Inhibiting c-Fos/NFATc1 Expression
Author:
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Medicine (miscellaneous)
Link
http://link.springer.com/article/10.1007/s13770-018-0116-z/fulltext.html
Reference25 articles.
1. Elliott P, O’Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK. Severe cardiovascular depression with remifentanil. Anesth Analg. 2000;91:58–61.
2. Ouattara A, Boccara G, Kockler U, Lecomte P, Leprince P, Leger P, et al. Remifentanil induces systemic arterial vasodilation in humans with a total artificial heart. Anesthesiology. 2004;100:602–7.
3. Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol. 2006;24:33–63.
4. Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol. 2009;29:555–67.
5. Kular J, Tickner J, Chim SM, Xu J. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem. 2012;45:863–73.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of Remifentanil on the Osteogenic Activity of Biodegradable Polyhydroxybutyrate Bone Cement in Orthopedic Surgery Model;Science of Advanced Materials;2023-12-01
2. The correlation of two bone turnover markers with bone mineral density: a population-based cross-sectional study;BMC Musculoskeletal Disorders;2023-08-24
3. Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods;BioMed Research International;2022-12-28
4. Chronic Pain after Bone Fracture: Current Insights into Molecular Mechanisms and Therapeutic Strategies;Brain Sciences;2022-08-09
5. Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis;Acta Biochimica et Biophysica Sinica;2022-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3